Canadian province may end seniors' free drugs

28 June 2001

The Canadian provincial government of Ontario is considering whether toend the provision of free prescription drugs for all seniors under the provincial drug plan, and also whether the program should be privatized.

Discussing the baby-boomer generation, which starts turning 65 within the next eight to 10 years, Health Minister Tony Clement told the National Post newspaper that, if "free drugs for the richest generation in the history of the world" is "what society deems to be the most important thing, I guess that's the consensus...I am questioning the consensus."

He also noted his concern at Ontario pharmacists' claims that manufacturers are charging as much as twice the government-set prices for drugs on the plan formulary. However, reports the Post, he did not commit himself to action over the claims.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight